Kimberly-Clark said on Monday it will buy Tylenol maker Kenvue KVUE.N in a cash-and-stock deal valued at about $48.7 billion, to create one of the biggest consumer health goods companies in the United States. Shares…

Investor Insight A cycle-aware gold developer-explorer focused on value creation at the steepest part of the Lassonde Curve – pairing a de-risked Canadian gold project with transformational discovery potential in Mexico, and overlaying partner-funded uranium…

Here are some charts that reflect our areas of focus this week at XLU Leads with New High Even though the Utilities SPDR (XLU) cannot keep pace with the Technology SPDR (XLK) and Communication Services…